Skip to content

Comparison of the Management of Post-prandial Hyperglycemia by Multiple Bolus Calculators

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01050868
Enrollment
24
Registered
2010-01-18
Start date
2009-06-30
Completion date
2009-12-31
Last updated
2016-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus Type 1

Brief summary

This prospective, non-randomized, non-controlled, interventional study will determine whether the Roche automated bolus caclulator (ABC) reduces post-meal hyperglycemia better than the competitor's ABC without causing significant hypoglycemia.

Interventions

DEVICEAccu-Chek Combo Kit mg DE/de

Sponsors

Hoffmann-La Roche
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Subjects \>/= 18 years at screening * Type 1 diabetics currently using an insulin pump for management of their diabetes and have been on a pump for at least at least 6 months prior to the screening visit * Subjects have to use a fast acting analog insulin * HbA1c = 9% (measured with DCA 2000) * Willing to perform periods of intensive blood glucose (BG) monitoring for up to 21 days prior to the study (\ 10 tests per day) with skipped meals and testmeals * Willing to use the 3 different bolus calculators during the course of the study * Willing to undergo planned hyperglycemia * Willing to perform high frequency BG monitoring (\> 20 / day) during the experiment

Exclusion criteria

* Type 2 Diabetes * Manifest severe late complications of diabetes (e.g. severe macro- or microangiopathy, severe neuropathy, severe retinopathy and/or severe nephropathy) * Current addiction to alcohol or substances of abuse * Pregnant or lactating women * Any known life-threatening disease

Design outcomes

Primary

MeasureTime frame
To compare the difference between the self-monitoring blood glucose (SMBG) value achieved at 6 hours after meals with induced post-prandial hyperglycemia and the mean target value of 110 mg/dL. Target post-prandial range is 80-140 mg/dL.6 hours after meal

Secondary

MeasureTime frame
To compare the absolute difference between the SMBG value and the target value between the calculators6 hours after meal
To compare theto compare the relative difference (multiplied by 100) between the SMBG value and the target value between the calculators6 hours after meal
To compare the absolute relative difference (RAD, multiplied by 100) between the SMBG value and the target value between the calculators6 hours after meal

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026